Filing Details
- Accession Number:
- 0001140361-17-038689
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-10-13 20:43:32
- Reporting Period:
- 2015-05-27
- Accepted Time:
- 2017-10-13 20:43:32
- Original Submission Date:
- 2015-05-28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238403 | K Daniel Spiegelman | C/O Biomarin Pharmaceutical Inc., 770 Lindaro St. San Rafael CA 94901 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-27 | 34,078 | $67.81 | 109,663 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-27 | 34,078 | $130.00 | 75,585 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2015-05-27 | 34,078 | $0.00 | 34,078 | $67.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 35,552 | 2013-11-15 | 2023-05-14 | No | 4 | M | Direct |
Footnotes
- On May 28, 2015, the reporting person filed a Form 4 which inadvertently failed to report this option exercise.
- Trade made pursuant to a 10b5-1 plan executed on March 11, 2015.
- On May 28, 2015, the reporting person filed a Form 4 which inadvertently reported an incorrect transaction date and deemed execution date. This amendment corrects such date.
- All shares sold at same price.
Billionaire Hedge Funds
